(VIANEWS) - KKR & Co. (KKR), First Mid Bancshares (FMBH), Harrow Health (HROW) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. KKR & Co. (KKR)
44.5% sales growth and 38.03% return on equity
KKR & Co.'s sales growth this year is expected to be 48.9% and 14.1% for next year.
Year-on-year quarterly revenue growth grew by 126%, now sitting on 24.31B for the twelve trailing months.
Volume
Today's last reported volume for KKR & Co. is 2730520 which is 1.85% below its average volume of 2782150.
KKR & Co.'s sales growth for the next quarter is 44.5%. The company's growth estimates for the present quarter and the next is 85.4% and 89.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 38.03%.
Volatility
KKR & Co.'s last day, last week, and last month's current volatility was 3.60%, 2.20%, and 1.85%, respectively.
KKR & Co.'s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.92% (day), 2.56% (last week), and 2.59% (last month), respectively.
KKR & Co.'s Stock Yearly Top and Bottom Value
KKR & Co.'s stock is valued at $73.54 at 16:22 EST, higher than its 52-week high of $73.48.
KKR & Co.'s Moving Average
KKR & Co.'s worth is way higher than its 50-day moving average of $64.19 and way above its 200-day moving average of $59.92.Previous days news about KKR & Co.(KKR)
- According to Bloomberg Quint on Tuesday, 19 October, "In 2004, for example, Arizona state regulators rejected the acquisition of Unisource Energy Corp., the parent company of Tuscan Electric, by private equity giant KKR & Co. Regulators did eventually approve the sale of UniSource, then known as UNS Energy Corp., in 2013 to Fortis Inc."
- According to Bloomberg Quint on Friday, 22 October, "Earlier this year, KKR & Co. disbursed $500 million of profits from the sale of manufacturer Ingersoll Rand Inc. to 16,000 workers at the Davidson, North Carolina-based industrial-equipment manufacturer."
2. First Mid Bancshares (FMBH)
39.7% sales growth and 7.12% return on equity
First Mid Bancshares, Inc., a financial holding company, provides community banking products and services to commercial, retail, and agricultural customers in the United States.
First Mid Bancshares's sales growth this year is expected to be 34.4% and 11.4% for next year.
Year-on-year quarterly revenue growth grew by 56.6%, now sitting on 194.56M for the twelve trailing months.
Volume
Today's last reported volume for First Mid Bancshares is 13736 which is 47.7% below its average volume of 26266.
First Mid Bancshares's sales growth for the next quarter is 39.7%. The company's growth estimates for the ongoing quarter and the next is 29% and 12.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.12%.
Volatility
First Mid Bancshares's last day, last week, and last month's current volatility was 1.33%, 0.88%, and 1.10%, respectively.
First Mid Bancshares's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.32% (day), 1.57% (last week), and 1.91% (last month), respectively.
First Mid Bancshares's Stock Yearly Top and Bottom Value
First Mid Bancshares's stock is valued at $42.00 at 16:22 EST, under its 52-week high of $45.00 and way higher than its 52-week low of $25.55.
First Mid Bancshares's Moving Average
First Mid Bancshares's value is above its 50-day moving average of $40.49 and above its 200-day moving average of $41.63.3. Harrow Health (HROW)
25.1% sales growth and 39.24% return on equity
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company.
Harrow Health's sales growth this year is expected to be 41.8% and 15.9% for next year.
Year-on-year quarterly revenue growth grew by 125%, now sitting on 62.57M for the twelve trailing months.
Volume
Today's last reported volume for Harrow Health is 56440 which is 54.43% below its average volume of 123872.
Harrow Health's sales growth for the next quarter is 25.1%. The company's growth estimates for the ongoing quarter and the next is a negative 106.2% and negative 0%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 39.24%.
Volatility
Harrow Health's last day, last week, and last month's current volatility was 0.10%, 1.96%, and 2.02%, respectively.
Harrow Health's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.91% (day), 7.22% (last week), and 5.32% (last month), respectively.
Harrow Health's Stock Yearly Top and Bottom Value
Harrow Health's stock is valued at $9.74 at 16:22 EST, way under its 52-week high of $11.24 and way higher than its 52-week low of $4.65.
Harrow Health's Moving Average
Harrow Health's worth is above its 50-day moving average of $9.70 and above its 200-day moving average of $8.93.4. Amkor Technology (AMKR)
20.6% sales growth and 19.84% return on equity
Amkor Technology, Inc. provides outsourced semiconductor packaging and test services in the United States and internationally.
Amkor Technology's sales growth this year is anticipated to be 21.5% and 9% for next year.
Year-on-year quarterly revenue growth grew by 19.9%, now sitting on 5.46B for the twelve trailing months.
Volume
Today's last reported volume for Amkor Technology is 1030760 which is 13.58% below its average volume of 1192770.
Amkor Technology's sales growth for the next quarter is 20.6%. The company's growth estimates for the current quarter and the next is a negative 0% and negative 0%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 19.84%.
Volatility
Amkor Technology's last day, last week, and last month's current volatility was 0.39%, 1.07%, and 1.72%, respectively.
Amkor Technology's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.20% (day), 2.85% (last week), and 3.20% (last month), respectively.
Amkor Technology's Stock Yearly Top and Bottom Value
Amkor Technology's stock is valued at $22.28 at 16:22 EST, way below its 52-week high of $29.50 and way above its 52-week low of $10.83.